What does CUSIP 92686J106 represent in this 13F holders report?

CUSIP 92686J106 is the security identifier for VKTX - Viking Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held VKTX - Viking Therapeutics, Inc. - Common Stock in Q2 2019?

150 institutional investors reported VKTX - Viking Therapeutics, Inc. - Common Stock for Q2 2019. Use the holders table for investor-level position and value details.

Viking Therapeutics, Inc. - Common Stock (VKTX)

CUSIP: 92686J106

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class: Equity / Common Stock
Shares outstanding: 115,694,154
Total 13F shares: 45,087,675
Share change: -224,983
Total reported value: $374,231,879
Put/Call ratio: 56%
Price per share: $8.30
Number of holders: 150
Value change: -$7,341,449
Number of buys: 72
Number of sells: 62

Quarterly Holders Quick Answers

What is CUSIP 92686J106?
CUSIP 92686J106 identifies VKTX - Viking Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2019
Previous quarter: Q1 2019

Recent filing periods for CUSIP 92686J106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of VKTX - Viking Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
STATE STREET CORP	13F	Company	6.2%	7,227,888	$71,845,000	—	31 Mar 2019	13F
ArrowMark Colorado Holdings LLC	13F	Company	3.9%	4,499,204	$44,722,000	—	31 Mar 2019	13F
BlackRock Finance, Inc.	13F	Company	3.6%	4,114,466	$40,896,000	—	31 Mar 2019	13F
VANGUARD GROUP INC	13F	Company	2.7%	3,109,641	$30,910,000	—	31 Mar 2019	13F
FMR LLC	13F	Company	2.7%	3,071,096	$30,527,000	—	31 Mar 2019	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	1.5%	1,757,000	$17,465,000	—	31 Mar 2019	13F
Park West Asset Management LLC	13F	Company	1.4%	1,572,507	$15,631,000	—	31 Mar 2019	13F
Fiera Capital Corp	13F	Company	1.2%	1,422,153	$14,136,000	—	31 Mar 2019	13F
CITADEL ADVISORS LLC	13F	Company	0.93%	1,073,574	$10,671,000	—	31 Mar 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.78%	900,014	$8,945,000	—	31 Mar 2019	13F
Sio Capital Management, LLC	13F	Company	0.74%	852,160	$8,470,000	—	31 Mar 2019	13F
Rubric Capital Management LP	13F	Company	0.7%	810,000	$8,051,000	—	31 Mar 2019	13F
NORTHERN TRUST CORP	13F	Company	0.65%	756,950	$7,524,000	—	31 Mar 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.58%	673,320	$6,692,000	—	31 Mar 2019	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.57%	654,300	$6,504,000	—	31 Mar 2019	13F
JENNISON ASSOCIATES LLC	13F	Company	0.44%	512,695	$5,096,000	—	31 Mar 2019	13F
Nicholas Investment Partners, LP	13F	Company	0.43%	494,730	$4,918,000	—	31 Mar 2019	13F
Opaleye Management Inc.	13F	Company	0.42%	485,000	$4,821,000	—	31 Mar 2019	13F
Rafferty Asset Management, LLC	13F	Company	0.39%	445,569	$4,429,000	—	31 Mar 2019	13F
Sculptor Capital LP	13F	Company	0.38%	435,600	$4,330,000	—	31 Mar 2019	13F
BAKER BROS. ADVISORS LP	13F	Company	0.37%	425,000	$4,225,000	—	31 Mar 2019	13F
MACQUARIE GROUP LTD	13F	Company	0.35%	402,306	$3,999,000	—	31 Mar 2019	13F
COLUMBUS CIRCLE INVESTORS	13F	Company	0.31%	358,777	$3,566,000	—	31 Mar 2019	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.29%	331,089	$3,291,000	—	31 Mar 2019	13F
RAYMOND JAMES & ASSOCIATES	13F	Company	0.28%	329,726	$3,277,000	—	31 Mar 2019	13F
Bank of New York Mellon Corp	13F	Company	0.28%	319,960	$3,181,000	—	31 Mar 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.27%	313,101	$3,113,000	—	31 Mar 2019	13F
BAILARD, INC.	13F	Company	0.27%	312,200	$3,103,000	—	31 Mar 2019	13F
Russell Investments Group, Ltd.	13F	Company	0.27%	312,051	$3,087,000	—	31 Mar 2019	13F
UBS Group AG	13F	Company	0.24%	272,402	$2,708,000	—	31 Mar 2019	13F
Healthcare Value Capital, LLC	13F	Company	0.22%	250,000	$2,485,000	—	31 Mar 2019	13F
Cornerstone Capital, Inc.	13F	Company	0.21%	244,800	$2,433,000	—	31 Mar 2019	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.21%	237,466	$2,360,000	—	31 Mar 2019	13F
C WorldWide Group Holding A/S	13F	Company	0.2%	232,138	$2,307,000	—	31 Mar 2019	13F
David M. Knott	13F	Individual	0.19%	218,102	$2,168,000	—	31 Mar 2019	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.18%	212,048	$2,108,000	—	31 Mar 2019	13F
Allianz Asset Management GmbH	13F	Company	0.16%	180,799	$1,797,000	—	31 Mar 2019	13F
DAFNA Capital Management LLC	13F	Company	0.15%	179,200	$1,781,000	—	31 Mar 2019	13F
Endurant Capital Management LP	13F	Company	0.15%	178,448	$1,774,000	—	31 Mar 2019	13F
ALPS ADVISORS INC	13F	Company	0.15%	172,603	$1,716,000	—	31 Mar 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.15%	171,757	$1,705,000	—	31 Mar 2019	13F
L & S Advisors Inc	13F	Company	0.15%	170,770	$1,698,000	—	31 Mar 2019	13F
Virtu Financial LLC	13F	Company	0.14%	163,782	$1,628,000	—	31 Mar 2019	13F
BLAIR WILLIAM & CO/IL	13F	Company	0.14%	163,283	$1,623,000	—	31 Mar 2019	13F
ESSEX INVESTMENT MANAGEMENT CO LLC	13F	Company	0.14%	158,341	$1,574,000	—	31 Mar 2019	13F
TEACHERS ADVISORS, LLC	13F	Company	0.13%	152,076	$1,512,000	—	31 Mar 2019	13F
APIS CAPITAL ADVISORS, LLC	13F	Company	0.13%	150,000	$1,491,000	—	31 Mar 2019	13F
JANE STREET GROUP, LLC	13F	Company	0.13%	149,387	$1,485,000	—	31 Mar 2019	13F
LPL Financial LLC	13F	Company	0.13%	145,785	$1,449,000	—	31 Mar 2019	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.13%	145,198	$1,443,000	—	31 Mar 2019	13F

Institutional Holders of Viking Therapeutics, Inc. - Common Stock (VKTX) as of Q2 2019

As of 30 Jun 2019, Viking Therapeutics, Inc. - Common Stock (VKTX) was held by 150 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 45,087,675 shares. The largest 10 holders included STATE STREET CORP, ArrowMark Colorado Holdings LLC, BlackRock Inc., VANGUARD GROUP INC, FMR LLC, Park West Asset Management LLC, Fiera Capital Corp, NORTHERN TRUST CORP, Sio Capital Management, LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 150 institutional shareholders reporting positions in this security for the Q2 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders

158

Q2 2019 holders

150

Holder diff

-8

Investor	Q1 2019 Shares	Q2 2019 Shares	Share Diff	Share Chg %	Q1 2019 Value $	Q2 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.